3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
20
Neoplasms
17
Lung Neoplasms
11
Carcinoma, Non-Small-Cell Lung
9
Uterine Cervical Neoplasms
5
Prostatic Neoplasms
5
Pancreatic Neoplasms
5
Colorectal Neoplasms
5
Brain Neoplasms
5
Ovarian Neoplasms
4
Myelodysplastic Syndromes
4
Melanoma
4
Leukemia, Myeloid, Acute
4
Carcinoma, Hepatocellular
4
Triple Negative Breast Neoplasms
3
Skin Neoplasms
3
Neoplasm Metastasis
3
Kidney Neoplasms
3
Carcinoma, Renal Cell
3
Uveal Melanoma
2
Recurrence
2
Myeloproliferative Disorders
2
Lymphoma, Non-Hodgkin
2
Lymphoma, B-Cell
2
Lymphoma
2
Lung Diseases
2
Hodgkin Disease
2
Head and Neck Neoplasms
2
Glioma
2
Glioblastoma
2
Interventions
Specimen Handling
4
Doxorubicin
4
pembrolizumab
3
Radiotherapy
3
Radiation
3
Magnetic Resonance Spectroscopy
3
Biopsy
3
pazopanib
2
palbociclib
2
Immunoglobulin G
2
Ifosfamide
2
toripalimab
1
talimogene laherparepvec
1
silmitasertib
1
selinexor
1
ribociclib
1
peposertib
1
mirdametinib
1
liposomal doxorubicin
1
eribulin
1
durvalumab
1
cemiplimab
1
abemaciclib
1
X-Rays
1
Vincristine
1
Temozolomide
1
Surgical Procedures, Operative
1
Radiotherapy, Intensity-Modulated
1
Proton Therapy
1
Nivolumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Liposarcoma
×
Blood Specimen Collection
×
90 days
×
Clear all
No trials found.